Spyre Therapeutics, Inc (SYRE) insider trading
Every open-market stock purchase and sale by Spyre Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Scott L Burrows (CFO) and 3 others sold $10.6M in the last 90 days.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $434M (25 sales). Last close $87.25 on Sep 3, 2026.
Recent SYRE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 2, 2026 | Scott L Burrows (CFO) | Sold | $1.6M |
| Sep 2, 2026 | Heidy King-Jones (Officer) | Sold | $36K |
| Sep 2, 2026 | Heidy King-Jones (Officer) | Bought (not open market) | — |
| Sep 1, 2026 | Heidy King-Jones (Officer) | Sold | $1.4M |
| Sep 1, 2026 | Cameron Turtle (CEO) | Sold | $732K |
| Sep 1, 2026 | Heidy King-Jones (Officer) | Sold | $547K |
| Sep 1, 2026 | Heidy King-Jones (Officer) | Sold | $419K |
| Sep 1, 2026 | Scott L Burrows (CFO) | Sold | $382K |
| Sep 1, 2026 | Cameron Turtle (CEO) | Sold | $326K |
| Sep 1, 2026 | Cameron Turtle (CEO) | Sold | $216K |
| Sep 1, 2026 | Scott L Burrows (CFO) | Sold | $177K |
| Sep 1, 2026 | Scott L Burrows (CFO) | Sold | $77.6K |
| Sep 1, 2026 | Heidy King-Jones (Officer) | Sold | $35.8K |
| Sep 1, 2026 | Cameron Turtle (CEO) | Sold | $35.6K |
| Sep 1, 2026 | Scott L Burrows (CFO) | Sold | $17.8K |
| Sep 1, 2026 | Heidy King-Jones (Officer) | Bought (not open market) | — |
| Sep 1, 2026 | Scott L Burrows (CFO) | Bought (not open market) | — |
| Aug 7, 2026 | Jeffrey W. Albers (Director) | Sold | $1M |
| Aug 7, 2026 | Jeffrey W. Albers (Director) | Sold | $835K |
| Aug 7, 2026 | Jeffrey W. Albers (Director) | Sold | $522K |
| Aug 7, 2026 | Jeffrey W. Albers (Director) | Bought (not open market) | — |
| Aug 3, 2026 | Cameron Turtle (CEO) | Sold | $681K |
| Aug 3, 2026 | Cameron Turtle (CEO) | Sold | $541K |
| Aug 3, 2026 | Scott L Burrows (CFO) | Sold | $486K |
| Aug 3, 2026 | Scott L Burrows (CFO) | Sold | $221K |
Who's trading SYRE
- Heidy King-Jones, Officer: sold $2.5M (5 sales), last Sep 2, 2026
- Scott L Burrows, CFO: sold $6.2M (18 sales), last Sep 2, 2026
- Cameron Turtle, CEO: sold $8.7M (31 sales), last Sep 1, 2026
- Jeffrey W. Albers, Director: sold $2.4M (3 sales), last Aug 7, 2026
- Fairmount Funds Management LLC, Insider: sold $400M (1 sale), last Jun 23, 2026
- Michael Thomas Henderson, Director: sold $8M (5 sales), last Jun 22, 2026
- Sheldon Sloan, C-suite exec: sold $6.6M (9 sales), last Jun 3, 2026
- Mark C. McKenna, Director: other filings, last May 27, 2026
- Sandra Milligan, Director: other filings, last May 27, 2026
- Laurie Stelzer, Director: other filings, last May 27, 2026
Get free alerts when an insider at Spyre Therapeutics, Inc files a new trade →